Tsai, J., Chien, A. L., Kim, N., Rachidi, S., Connolly, B. M., Lim, H., … Garza, L. A. (2021). Topical timolol 0.5% gel-forming solution for erythema in rosacea: A quantitative, split-face, randomized, and rater-masked pilot clinical trial. J Am Acad Dermatol, 85(4), 1044–1046. https://doi.org/10.1016/j.jaad.2021.01.098

Tsai, Jerry, Anna L. Chien, Noori Kim, Saleh Rachidi, Brian M. Connolly, Hester Lim, Sabrina Sisto Alessi César, Sewon Kang, and Luis A. Garza. “Topical timolol 0.5% gel-forming solution for erythema in rosacea: A quantitative, split-face, randomized, and rater-masked pilot clinical trial.” J Am Acad Dermatol 85, no. 4 (October 2021): 1044–46. https://doi.org/10.1016/j.jaad.2021.01.098.

Tsai J, Chien AL, Kim N, Rachidi S, Connolly BM, Lim H, et al. Topical timolol 0.5% gel-forming solution for erythema in rosacea: A quantitative, split-face, randomized, and rater-masked pilot clinical trial. J Am Acad Dermatol. 2021 Oct;85(4):1044–6.

Tsai, Jerry, et al. “Topical timolol 0.5% gel-forming solution for erythema in rosacea: A quantitative, split-face, randomized, and rater-masked pilot clinical trial.” J Am Acad Dermatol, vol. 85, no. 4, Oct. 2021, pp. 1044–46. Pubmed, doi:10.1016/j.jaad.2021.01.098.

Tsai J, Chien AL, Kim N, Rachidi S, Connolly BM, Lim H, Alessi César SS, Kang S, Garza LA. Topical timolol 0.5% gel-forming solution for erythema in rosacea: A quantitative, split-face, randomized, and rater-masked pilot clinical trial. J Am Acad Dermatol. 2021 Oct;85(4):1044–1046.